Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
- Status
- RECRUITING
- Phase
- PHASE1
Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
- Status
- RECRUITING
- Phase
- PHASE2
The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
- Status
- SUSPENDED
- Phase
- PHASE1
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Combination Therapy for BRAF-V600E Metastatic CRCm
- Status
- RECRUITING
- Phase
- PHASE2
Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Study of BND-35 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1